Facebook to ban ads promoting weapon accessories, protective gear in US    Explainer: Road to Palestinian vote full of obstacles    Tennis: Australian Open arrivals hit by 4 COVID-19 positive tests    US state capitals, Washington on alert for possible pro-Trump armed protests    US federal prisons on lockdown in run-up to Biden inauguration    In Photos: Egyptian archaeological mission at Saqqara Necropolis announces new major discoveries    Armin Laschet picked as new leader of Germany's CDU party    Talaat Moustafa Group's subsidiary gets approval to develop 5k feddans in Capital Gardens City    Bahrain's Bank ABC completes $480m acquisition of Blom Bank Egypt    Egypt reports 879 new coronavirus cases, 52 deaths on Friday    14.7% increase in health expenditures during H1 of FY 2020/21: Maait    State revenues expected to drop by EGP 150 bln in FY 2020/21 owing to coronavirus    Tennis: Australian Open arrivals hit by 2 COVID positive tests    Ferguson says management all about results, backs Rooney to succeed at Derby    ‘This is not a game': Global virus death toll hits 2 million    Egypt's Sisi discusses bilateral ties, regional developments with Sudanese delegation    Egypt's Mostaqbal Watan party dominates the leading posts of parliament's 25 committees    Egypt's budget deficit to GDP ratio receded to 3.6% in first half of FY2020/21, revenues rose by 16%    Mubarak-era politician Safwat El-Sherif dies aged 88    Handball: Egypt ease past Chile 35-29 in World Championship opener    Egypt's president, Siemens CEO discuss final deal on construction of electric train system    Hollywood actor Mena Massoud visits Giza pyramids, says is proud of Egyptian culture    Egypt confirms 970 new coronavirus cases, 55 deaths on Tuesday    EgyptAir to operate daily flight to Doha after lifting airspace ban on Qatar    Pound shielded from Covid-19    Egypt reopens airspace and resumes flights with Qatar    Egypt, Tunisia to establish maritime trade route    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Pfizer, BioNTech apply for coronavirus vaccine approval in Europe
Published in Amwal Al Ghad on 01 - 12 - 2020

U.S. pharmaceutical giant Pfizer and its German partner BioNTech said they have applied to the European Medicines Agency for the conditional marketing authorization of their coronavirus vaccine.
If the authorization is granted, it could enable use of the vaccine in Europe this month, BioNTech said.
Such authorization is granted to medicines "that address unmet medical needs of patients on the basis of less comprehensive data than normally required," the EMA says on its website.
"In the interest of public health, applicants may be granted a conditional marketing authorisation for such medicines where the benefit of immediate availability outweighs the risk of less comprehensive data than normally required," it adds. The applicant should be in a position to provide comprehensive clinical data in the future.


Clic here to read the story from its source.